QQ客服 官方微博 反馈留言

	Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress
	Lin, Jiamao; Fang, Lijun; Li, Hui; Li, Zhenxiang; Lyu, Linmao; Wang, Haiyong; Xiao, Jun
刊名	EUROPEAN JOURNAL OF PHARMACOLOGY
	2019
卷号	859
关键词	Doxorubicin Cardiotoxicity Astragaloside IV NAPDH oxidase
DOI	10.1016/j.ejphar.2019.172490
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4531098
专题	山东大学
作者单位	Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Internal Med Oncol, Jinan 250117, Shandong, Peoples R
推荐引用方式 GB/T 7714	Lin, Jiamao,Fang, Lijun,Li, Hui,et al. Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress[J]. EUROPEAN JOURNAL OF PHARMACOLOGY,2019,859.
APA	Lin, Jiamao.,Fang, Lijun.,Li, Hui.,Li, Zhenxiang.,Lyu, Linmao.,...&Xiao, Jun.(2019).Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress.EUROPEAN JOURNAL OF PHARMACOLOGY,859.
MLA	Lin, Jiamao,et al."Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress".EUROPEAN JOURNAL OF PHARMACOLOGY 859(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。